BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16218468)

  • 1. Atherogenesis and autoimmune disease: the model of lupus.
    Bruce IN
    Lupus; 2005; 14(9):687-90. PubMed ID: 16218468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atherosclerosis in systemic lupus erythematosus].
    Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
    Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand?
    Nikpour M; Gladman DD; Urowitz MB
    Lupus; 2013 Oct; 22(12):1243-50. PubMed ID: 24097996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Accelerated atherosclerosis in autoimmune diseases].
    Alba PB
    Rev Fac Cien Med Univ Nac Cordoba; 2008; 65(4):121-2. PubMed ID: 20803942
    [No Abstract]   [Full Text] [Related]  

  • 7. Intima media thickness measurement as a marker of subclinical atherosclerosis in SLE patient.
    Smrzova A; Horak P; Skacelova M; Hermanova Z; Langova K; Zadrazil J; Novotny D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):404-11. PubMed ID: 23945845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis, therapy and prognosis in systemic autoimmune disorders like lupus erythematosus].
    Bolten WW; Waldorf-Bolten E
    Versicherungsmedizin; 2004 Dec; 56(4):163-9. PubMed ID: 15633767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis.
    George J; Harats D; Gilburd B; Levy Y; Langevitz P; Shoenfeld Y
    Lupus; 1999; 8(3):220-6. PubMed ID: 10342715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of autologous stem cell transplantation in patients with systemic lupus erythematosus.
    Hahn BH
    J Rheumatol Suppl; 1997 May; 48():89-93. PubMed ID: 9150126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature coronary heart disease in SLE: can we prevent progression?
    Iaccarino L; Bettio S; Zen M; Nalotto L; Gatto M; Ramonda R; Punzi L; Doria A
    Lupus; 2013 Oct; 22(12):1232-42. PubMed ID: 24097995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: the potential role for regulatory T cells.
    Tu H; Li Q; Xiang S; Jiang H; Mao Y; Shou Z; Chen J
    Atherosclerosis; 2012 May; 222(1):29-33. PubMed ID: 22417842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis in systemic lupus erythematosus.
    Sherer Y; Zinger H; Shoenfeld Y
    Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis in systemic lupus erythematosus.
    Croca S; Rahman A
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):364-372. PubMed ID: 29224678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.
    Zinger H; Sherer Y; Shoenfeld Y
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):20-8. PubMed ID: 18991025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessing the cardiovascular risk in patients with systemic lupus erythematosus].
    Arnaud L; Mathian A; Bruckert E; Amoura Z
    Rev Med Interne; 2014 Nov; 35(11):723-9. PubMed ID: 25234464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspects of atherosclerosis and metabolic syndrome in lupus erythematosus].
    Nascimento IS; Quaio CR; Sinicato NA; Appenzeller S; de Carvalho JF
    Acta Reumatol Port; 2010; 35(3):294-300. PubMed ID: 20975632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.